Scientific article
French

Dépistage du cancer de la prostate: utilité, buts et perspectives en 2010

Published in

Revue médicale suisse, vol. 6, no. 274, p. 2336-2339

Publication date

2010

Abstract

According to recent results of a sub-group of 20,000 patients from the ERSPC study, prostate cancer screening significantly increases disease specific survival for men with a life expectancy of 15 years. However presently, only 20% of prostate biopsies lead to the diagnosis of cancer. This low yield may be increased by using new tools on their way to validation, such as the blood and urinary markers p2-PSA and PCA3, so as MRI and tridimensional computerized echography. Finally, the tumours detected must be managed with subtlety, since a third of them are not overtly aggressive clinically. Hence, a significant proportion of such tumours may not need immediate curative intent treatment, and can be followed up in an active surveillance protocol.

Keywords

  • Humans
  • Male
  • Mass Screening/methods
  • Prostatic Neoplasms/diagnosis/prevention & control

Citation (ISO format)

ISELIN, Christophe, JICHLINSKI, Patrice. Dépistage du cancer de la prostate: utilité, buts et perspectives en 2010. In: Revue médicale suisse, 2010, vol. 6, n° 274, p. 2336–2339.

Main files (1)

Article (Published version)

Identifiers

Additional URL for this publication

http://rms.medhyg.ch/numero-274-page-2336.htm

Journal ISSN

1660-9379
516views
0downloads

Technical informations

Creation

17/10/2013 14:48:00

First validation

17/10/2013 14:48:00

Update

14/03/2023 20:45:07

Status update

14/03/2023 20:45:07

Last indexation

30/10/2024 15:29:11
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated